CTCA depends on its technology infrastructure for operating comprehensive electronic health records, specialized clinical programmes, customer relationship management and enterprise resource planning applications. Its highly integrated systems allow the organisation to maintain all-digital operations with 100 percent uptime to ensure patient care and safety.
CTCA evaluated HP against other well-known hardware vendors offering competing server technologies. HP ProLiant servers were chosen based on the capabilities of the technology, including ease of management, along with the strength of HP's product roadmap and cost-effective price.
To date, CTCA has deployed more than 500 HP ProLiant servers, including 200 blade servers, in its production and disaster recovery sites around the country. The CTCA environment runs on a combination of HP ProLiant DL580, DL380, DL560, BL460c, BL480c and BL260c servers.
"The growth of our organisation required expanding our infrastructure to effectively respond to our needs", stated Chad A. Eckes, chief information officer, Cancer Treatment Centers of America. "HP's innovative blade server technology delivers increased performance and reliability while ensuring the 100 percent uptime our mission-critical business applications require. This powerful technology infrastructure translates to improved care for our patients."
CTCA relies on the easy-to-use HP Insight Control (IC) management console for a 24/7 view of its infrastructure. In addition to monitoring server health and performance, the console aids in deploying new servers quickly and decreasing the organisation's technology management costs. CTCA plans to invest in additional HP servers in the coming years on a project-by-project basis to continue to improve the lives of cancer patients.
HP simplifies the technology experience for consumers and businesses with a portfolio that spans printing, personal computing, software, services and IT infrastructure. More information about HP is available in the VMW April 2009 article HP and Partners HealthCare extend collaboration in support of personalized medicine.